2型糖尿病患者睡眠时长与心血管疾病发病及死亡风险的关系
该前瞻性研究纳入英国生物银行基线无心血管疾病和癌症的18,876例2型糖尿病患者,平均随访11.0-12.0年,记录2,570例动脉粥样硬化性心血管疾病(ASCVD)发病和598例心血管疾病死亡。与每日睡眠7小时相比,≤5小时和≥10小时与ASCVD发病及心血管疾病死亡风险升高独立相关。
要点
- 与每日睡眠7小时相比,≤5小时和≥10小时与ASCVD发病风险升高相关(HR 1.26和1.41)。
- 与每日睡眠7小时相比,≤5小时和≥10小时与心血管疾病死亡风险升高相关(HR 1.42和1.85)。
- 在多数敏感性分析及睡眠时长与代谢控制或糖尿病严重程度的联合分析中观察到相似结果。
核心结论
- 在2型糖尿病患者中,短睡眠时长和长睡眠时长均与心血管疾病发病和死亡风险升高独立相关。
研究设计与样本
- 前瞻性研究,纳入英国生物银行基线无心血管疾病和癌症的18,876例2型糖尿病患者。
- 通过基线问卷获取习惯性睡眠时长,采用Cox比例风险回归模型分析睡眠时长与心血管疾病事件的关系。
主要发现
- 平均随访11.0-12.0年,记录2,570例ASCVD发病和598例心血管疾病死亡。
- 与每日睡眠7小时相比,≤5小时和≥10小时与ASCVD发病风险升高相关(HR 1.26,95%CI 1.08-1.48;HR 1.41,95%CI 1.16-1.70)。
- 与每日睡眠7小时相比,≤5小时和≥10小时与缺血性卒中风险升高相关(HR 1.70,95%CI 1.23-2.35;HR 2.08,95%CI 1.44-3.01)。
- 与每日睡眠7小时相比,≥10小时与外周动脉疾病风险升高相关(HR 1.45,95%CI 1.01-2.10),≤5小时与外周动脉疾病风险无显著关联(HR 1.02,95%CI 0.72-1.44)。
- 与每日睡眠7小时相比,≤5小时和≥10小时与心血管疾病死亡风险升高相关(HR 1.42,95%CI 1.02-1.97;HR 1.85,95%CI 1.30-2.64)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: People with type 2 diabetes may have insufficient or prolonged sleep that could accelerate cardiovascular disease (CVD) onset, but existing evidence from prospective studies has been limited. We examined the association of sleep duration with CVD incidence and mortality in this high-risk population. RESEARCH DESIGN AND METHODS: This prospective study included 18,876 participants with type 2 diabetes in the UK Biobank who were free of CVD and cancer at baseline. Habitual sleep duration was obtained using a baseline questionnaire. Cox proportional hazards regression models were used to examine the association between sleep duration and CVD events. RESULTS: During an average follow-up of 11.0-12.0 years, we documented 2,570 incident cases of atherosclerotic cardiovascular disease (ASCVD) and 598 CVD deaths. Compared with sleeping for 7 h/day, the multivariable-adjusted hazard ratios of ≤5 and ≥10 h/day were 1.26 (95% CI 1.08, 1.48) and 1.41 (1.16, 1.70) for incident ASCVD, 1.22 (0.99, 1.50) and 1.16 (0.88, 1.52) for coronary artery disease, 1.70 (1.23, 2.35) and 2.08 (1.44, 3.01) for ischemic stroke, 1.02 (0.72, 1.44) and 1.45 (1.01, 2.10) for peripheral artery disease, and 1.42 (1.02, 1.97) and 1.85 (1.30, 2.64) for CVD mortality. Similar results were observed in most sensitivity analyses that aimed to address potential reverse causation and in the joint analyses of sleep duration and metabolic control or diabetes severity status. CONCLUSIONS: Short and long sleep durations were independently associated with increased risks of CVD onset and death among people with type 2 diabetes.
引用
- Han H, Wang Y, Li T, et al. Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes. Diabetes Care. 2023. PMID: 36383480. doi:10.2337/dc22-1127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。